Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FRBV0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,988
Award facts
- Contract value 100% obligated
- $19,988.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $20,000 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The award was issued on November 17, 2025, with an ultimate completion date of December 9, 2025, under a firm fixed-price delivery order contract with no set-aside designation. DMS Pharmaceutical Group is performing as the sole prime contractor with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) established through the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical and medical supply support to military healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, with a 30-month base period followed by three optional 30-month periods. EXPAREL, a specialty surgical anesthetic product, represents one of the diverse pharmaceutical categories within DMS Pharmaceutical Group's authorized product portfolio, which encompasses branded and generic prescription medications, biologics, vaccines, and medical consumables supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FRBV0?
SPE2DR26FRBV0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FRBV0 worth?
The government has obligated $19,988 on SPE2DR26FRBV0.
Is contract SPE2DR26FRBV0 an order under another contract?
Yes. SPE2DR26FRBV0 is a delivery order under SPE2DR25D9206, an indefinite delivery contract.
Was contract SPE2DR26FRBV0 competed?
The extent of competition for SPE2DR26FRBV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award